How much funding has Eiger Biopharmaceuticals raised?

Eiger Biopharmaceuticals has raised $7.1M in total funding, most recently a Series A round.

Who are Eiger Biopharmaceuticals's investors?

Eiger Biopharmaceuticals's investors include InterWest Partners, Vivo Capital.

When was Eiger Biopharmaceuticals founded?

Eiger Biopharmaceuticals was founded in 2008.

Where is Eiger Biopharmaceuticals headquartered?

Eiger Biopharmaceuticals is headquartered in Palo Alto, California, United States.

What industry is Eiger Biopharmaceuticals in?

Eiger Biopharmaceuticals operates in Biotech, Healthcare.

How many employees does Eiger Biopharmaceuticals have?

Eiger Biopharmaceuticals has 11-50 employees.

Eiger Biopharmaceuticals

IPO

Palo Alto, United States · Founded 2008 · $7.1M raised

Biotech

Healthcare

Headquarters: Palo Alto, California
Employees: 11–50
Founded: 2008
Business Model: B2B

Website: eigerbio.com
Total Funding: $7.1M
Last Round: $7.1M Series AAug 2012
Rounds: 1

About

Eiger BioPharmaceuticals (formerly Celladon Corp) was a commercial-stage biopharmaceutical company founded in 2008 and headquartered in Palo Alto, California, focused on developing and commercializing targeted therapies for serious rare and ultra-rare diseases. The company achieved FDA approval of Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and pursued treatments for Hepatitis Delta (HDV) and other orphan diseases. Following a series of clinical setbacks, Eiger filed for bankruptcy in 2024 and wound down operations.

Summary

Eiger Biopharmaceuticals is a Biotech company based in Palo Alto, United States, founded in 2008. It has raised $7.1M in total across 1 round, most recently a $7.1M Series A round in Aug 2012. Investors include InterWest Partners and Vivo Capital.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Debt FinancingDebt FinancingJun 2022

$75.0M

Jun 2022

Sign up to see all 3 rounds

Series A through Debt Financing — per-round amounts, valuations, and who invested in each round.

Investors

InterWest Partners

Lead

1 round

Vivo Capital

Lead

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth Equity·$5.1B·Aug 2022

IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare

Private Equity·$3.3B·Apr 2022

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private Equity·$3.0B·Jan 2004

inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare

Private Equity·$3.0B·May 2017

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech

Series A·$3.0B·Jan 2022

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology

Corporate Round·$2.8B·Jan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/eiger-biopharmaceuticals"><img src="https://indexed.vc/api/badge/company/eiger-biopharmaceuticals" alt="Eiger Biopharmaceuticals on Indexed.vc" width="260" height="76" /></a>